Menu X
Our Solutions
Healthcare Organizations
Partner with Us
Contact Us
Novaseek is transforming how scientists and clinical researchers access real world clinical data and human biospecimens to power life sciences R&D in the era of precision medicine and population health management.

Novaseek’s award-winning novel cloud platform, the Clinical Data Network for Research (CDNR), easily interfaces with hospital data sources, and enables researchers to define patient cohorts through population analytics and to obtain biospecimens with longitudinal consented data to advance translational medicine, clinical development and post-launch observational studies.

Our Vision is a world where a clear understanding of real-world patients is central to every stage of life sciences research and drug development.

Ready to receive
biospecimens and associated
clinical data?
Complete a Request Form NOW!

Our Solutions

Novaseek Research advances the development of new treatments via its turnkey solutions for observational and real-world data studies, including accessing fully consented biospecimens with associated clinical longitudinal data for research. Its novel Clinical Data Network For Research (CDNR) platform meets the needs of organizations involved in procurement of biospecimens, accrual of patients and use of clinical data to support biomedical research. Our customers include:

  • Bio-Pharma companies involved in drug, device or diagnostic development
  • CROs involved in selecting and recruiting research subject cohorts
  • Researchers conducting observation and real world data studies
  • Entities involved in developing biobanks and patient registries
  • Government and academic research organizations that use biospecimens and clinical data
Novaseek addresses such common challenges as:

  • Insufficient numbers of biospecimens and lack of detailed clinical annotation
  • Difficulty with longitudinal collection of biospecimens and clinical data
  • Lack of access to or transparency of real-world clinical data
  • Inability to prospectively identify patients who meet specific clinical parameters (such as treatment history, diseases, etc.)
  • Inefficient patient consent processes
Novaseek solves these problems in a unique fashion with its CDNR platform that:

  • Uses the electronic medical record (EMR) and other clinical data sources to extract demographic and detailed longitudinal data, such as diagnoses, medications and lab test results
  • Matches EMR data against both research specifications and available laboratory specimens
  • Helps define and track consented patient cohorts and supports the collection of biospecimens at various time points
  • Synthesizes all the donor and biospecimen data for easy reference by end-user researchers
Novaseek works with customers in several ways:

  • As a provider of biospecimens and associated data collected from Novaseek’s own network of hospitals
  • By subscription to the CDNR platform – for companies and research organizations with ongoing needs for biospecimens and/or data. Subscribers use CDNR to plan and recruit cohorts, manage biospecimen requests and track clinical data
  • By licensing CNDR to organizations that want to facilitate biospecimen and associated clinical data acquisitions, and to streamline patient consenting and recruitment for research projects and clinical trials within their own clinical sites
The CDNR platform offers a turn-key, intuitive user experience and ensures clinical relevance and significance of every experiment and every study. Never be limited by not having clinical patient data or the right biospecimens for your projects!
Novaseek App Demo
BiospecimensCDNR PlatformCDNR License

For Healthcare Organizations

Novaseek Research enables healthcare organizations and consenting patients to share clinical data and biospecimens for research to generate new revenue, and advance medical research and precision medicine.  Novaseek and healthcare organizations within its network use approved protocols and patient consents to ensure the ethical conduct of research and respect for all participants.

Find Out More

About Novaseek

Novaseek is transforming how researchers access clinical data and human biospecimens. CDNR was developed by experts in drug development, hospital operations, and health IT to create a win-win for industry, academia, healthcare partners and patients.


Kate Torchilin
Kate Torchilin, PhD, MBA
Chief Executive Officer
Bennett Malbon
Bennett Malbon, MBA
VP of Technology
Steve DiPalma
Steve DiPalma
Chief Financial Officer
Derek Tillemans
Derek Tillemans
VP of Business Development, Healthcare Organizations

Partner with Us

Novaseek Research was founded by a management team with 100+ combined years of experience in life sciences, Health IT and hospital markets. We understand life sciences R&D. We understand clinical data. We understand hospitals and clinical laboratory operations. Contact us to learn how the Novaseek CDNR platform can become an integral part of your discovery, clinical research, post-launch studies and precision medicine initiatives.

Novaseek Presentation


Press Releases/Articles Icon

Press Releases & Articles

Novaseek Scouts CRO and Pharma Partners for its Clinical Data Platform

Novaseek is pursuing CROs and pharmas to employ its clinical data platform, Clinical Data Network for Research (CDNR), said CEO Kate Torchilin in an interview with this news service at the Biotech Showcase conference in San Francisco.

C-Suite Outlook: Leading Through Extraordinary Change

PharmaVoice 2017: “All of us in life sciences and healthcare are privileged to be working in an industry that is constantly evolving and re-inventing itself to better serve patients and help them live healthier lives. Of course, the patient is always the central theme of everything that we do; however, as we move into 2017, […]

Startup Novaseek Aims to Streamline Collection of Patient Data, Samples

With its goal of streamlining the process of collecting patient data, Cambridge, Massachusetts-based start-up Novaseek is tackling one of the more challenging portions of the diagnostics and drug-development processes.

Novaseek Research Announces Important Feature Enhancements to CDNR Platform for Biologically-Enhanced Real World Data

— Biospecimens enriched with deep data insights for population analytics, prospective patient tracking and more — CAMBRIDGE, MA, Jan. 9, 2017– Novaseek Research LLC today announced that its Clinical Data Network for Research (CDNR) platform was recently enhanced to include the capability to dynamically collect biospecimens and clinical data from patients during the course of […]

Read More

Biologically Enhanced Real-World Data: A Winning Formula for Drug Development

Technological advances in an ever-changing healthcare environment, including the digitization of patient health records, have had a significant impact on the development of new therapies. Since first being used to support a drug’s value, real-world data (RWD) is now being pulled into the R&D process at earlier stages to impact the development of new medicines […]

More Press Releases & Articles
RSS Icon


The HBS Kraft Precision Medicine Accelerator: A Powerful Voice in Precision Medicine

Last Thursday Novaseek Research had the chance to listen in on the Harvard Business School Kraft Precision Medicine Accelerator Oncology Data Landscape Update call. The Kraft Accelerator was established last year to speed breakthroughs in precision medicine. The Accelerator aims to enable faster commercialization of high-impact innovations by addressing challenges that slow the advancement of […]

Read More

Musings from the Digital Medicine Showcase

Last month I had the opportunity to present Novaseek’s CDNR platform at the second annual Digital Medicine Showcase. This event is a part of the Biotech Showcase event that takes place during the J.P. Morgan Annual Healthcare Conference. Digital Medicine Showcase brings together innovative companies and gives them a forum to present their clinically impactful […]

Read More

Leveraging the Power of Data: The Role of Patient Consent and Efficiency

Last month, Foundation Medicine and Flatiron Health announced an initiative to assemble large genomic databases built around the electronic health records (EHRs), of 20,000 cancer patients. The purpose of this initiative would be to provide a real world data-based tool for oncology reseachers. It’s exciting to think about the possibilities that this type of database […]

Read More

Aligning Drug Development to More Accurately Reflect the Real-World Patient

With the advance of precision medicine, ensuring that clinical studies more accurately reflect real-world patients needs to be at the heart of drug discovery and development. Historically, one of the reasons that so many studies fail is because patient cohorts are often not defined optimally for the treatment being investigated. Step one in changing this […]

Read More

How Researchers at Biopharma Companies and Academia Can Gain Better Insights into Real-World Clinical Phenotype Data To Improve Clinical Development

Precision medicine is an exciting area of innovation for researchers in academia and industry. It holds the promise of better outcomes for patients, and it is changing the way patients experience disease and treatment. By definition, the patient population for a targeted medicine is smaller than that of the disease category as a whole. Medicines affect patients differently.1 […]

Read More
More Blog Posts

Contact Us

Thank you for your interest in Novaseek! To contact our team or request a demo please fill out the form below and we will get back to you as soon as we can. You can also call us at 1-888-632-4311.

Lets Connect

default_rss default_email default_linkedin